Navari
2021-09-02 10:40 by Jonas Sandwall
Navari is solving a navigation-issue that surgeons encounter during laparoscopic liver surgery when removing liver tumours. Today, the most beneficial way for the patient is to have a tumour removed minimally-invasive, i.e. through laparoscopic surgery. However, surgeons face a big challenge when operating through a limited point of view, trying to orient themselves via the laparoscopic camera. By using existing gadgets and screens in the surgery room, Navari develops a software that provides the surgeon with a live-streamed augmented reality image on top of the already existing image provided by the laparoscopic camera. This helps the surgeons to orient themselves during the surgery, enabling them to locate and remove the tumour in the safest way possible.
Digital grammars
2018-05-30 13:42 by Jonas Sandwall
With language technology, Digital Grammars provides multilingual machine translation that is specialised, explainable and dependable.
Sigmastocks
2015-09-09 08:59 by Jonas Sandwall
Sigmastocks make stock trading easier for individuals and facilitate both the selection and buying process. Since the start in 2014 Sigmastocks have shaken up the financial sector and has been named Best Fintech 2018 by Nordic Startup Awards and one of the most promising startups by the 33-list. They challenge managed equity funds and want to change the financial sector in a positive way by using flat rates. With quantitative analysis and optimization, they develop algorithms that are trying to outperform market indexes.
1928 Diagnostics
2015-08-13 14:28 by Jonas Sandwall
Antibiotic resistant bacteria is an emerging and serious threat to human health since some bacterial infections can no longer be treated with antibiotics. 1928 Diagnostics contributes to save the power of antibiotics by providing the 1928D platform, a cloud service that enables hospitals and authorities worldwide to use and interpret DNA data from bacteria for antibiotic treatment decision support and outbreak monitoring.
The 1928D platform will allow users to share data and thus strengthen global collaboration in tracking bacteria, increased infection control and more efficient use of antibiotics. The 1928D DNA data crunching platform will save lives, costs for hospitals and society and pave the path for more sustainable use of antibiotics.